Stock Exchange & Press Releases 2022

Print Print this release
November 10, 2022

Medica 2022: Bittium Exhibits Its High-Tech Medical Technology Products and R&D Services

Press Release

Free for release on November 10, 2022, at 2.15 pm (CET +1)

Medica 2022: Bittium Exhibits Its High-Tech Medical Technology Products and R&D Services

Oulu, Finland, November 10, 2022 – Bittium exhibits its innovative products and solutions for cardiology and neurophysiology, as well as R&D services for developing medical and healthcare technology, at the Medica 2022 event. It is the world’s biggest trade fair for the medical market, and it will be held in Düsseldorf, Germany on November 14-17, 2022.

Bittium’s team of Medical Technologies experts is showcasing advanced high-tech solutions for monitoring heart, brain, and sleep-related breathing disorders. The solutions enable early detection of abnormalities in the body’s electrical activities and sleep-disordered breathing, thus speeding up the diagnosis and further treatment of a patient. All Bittium’s cardiology and neurophysiology measurement solutions are integrated with the cloud-based back-end systems that enable the analysis of data regardless of location.

The latest addition to the offering of medical technology products on display at the event is our Home Sleep Apnea Testing (HSAT) solution which consists of a measuring device, analysis software, tailored accessories, and a service platform. This end-to-end solution utilizes artificial intelligence to speed up analysis work. The solution focuses on Home Sleep Apnea Testing and aims to record PG (polygraphy) level data and analyze typical sleep-related breathing disorders. Registration of sleep-disordered breathing at home is an easy, cost-effective, and quick way for a patient to find out if the patient suffers from a sleep-related breathing disorder and, if necessary, to get access to treatment quickly.

Bittium’s team of Connectivity Solutions experts is showcasing technology know-how that enables, for example, the development of innovative wireless devices that use the latest technologies and can be used in the areas of healthcare and well-being. Customers using the R&D services benefit from Bittium’s strong expertise and experience in all stages of product development, including versatile know-how of both hardware and software, as well as specialized expertise in wireless connectivity and information security. The high quality of the product development projects is based on processes carried out according to the ISO 13485 certificate. 

The latest addition to the offering of R&D services is Bittium Cellular IoT Solution . The solution eases the development of technology products for remote healthcare and monitoring of well-being and enables wireless data transfer directly to cloud services over mobile networks. The solution will be demonstrated at stand 12/D33 showcasing Bittium’s R&D services.

Medica Connected Healthcare Forum

Bittium will have a speaker slot at the Medica Connected Healthcare Forum located at stand 12/E37. The topic of the speech is “Benefits of Cellular Connectivity in Remote Care”. Bittium’s speaker is Mr. Anders Berghäll, Sales Director, and the speech will take place on Monday, November 14th at 12:35.

The Medical Technologies team is located at stand 9/C15 and will be exhibiting the following products and solutions:

Products and solutions for cardiology:

  • Bittium Faros™ ECG measuring and monitoring device
  • Bittium Cardiac Navigator™ analysis software for ECG measurement data
  • Bittium OmegaSnap™ a family of disposable ECG patch electrodes
  • Bittium HolterPlus™ web-based remote cardiac monitoring solution

Products and solutions for neurophysiology:

  • Bittium Respiro™ a modern sleep apnea screening device (HSAT- Home Sleep Apnea Testing)
  • Bittium Respiro Analyst™ analysis software for sleep apnea measurement data
  • Bittium BrainStatus™ a compact EEG measuring and monitoring system
  • Bittium BrainStatus™ with Cerenion C-Trend for measuring the brain function of intensive care patients
  • Bittium NeurOne™ the most accurate EEG measuring device

Visit for more information on the offering.

The R&D services team is located at stand 12/D33 and exhibiting the following services:

  • Wireless solutions - One of Bittium’s core competencies is mastering different radio and antenna technologies and their application to different solutions using wireless connectivity. Bittium's in-house RF and antenna test laboratories support the development work and enable comprehensive project deliveries to the customers.
  • Innovative, power-optimized devices - Bittium specializes in the development of small, power-optimized devices that include different sensors. The device development expertise is complemented with strong know-how of embedded software and the combination enables the development of different types of systems for demanding environments.
  • Standards-based services - The high quality of Bittium’s R&D services is based on processes carried out according to the ISO 13485 certificate, and Bittium’s in-house test laboratories are utilized in the verification and validation of the products.

Visit for more information on the offering.

Further information:

Antti Näykki
Senior Vice President, Medical Technologies
Tel. +358 (0)40 3443507

Tommi Kangas
Senior Vice President, Connectivity Solutions
Tel. +358 40 344 3507


Main media


Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its over 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology and neurophysiology. Net sales in 2021 were EUR 86.9 million and operating profit was EUR 3.2 million. Bittium is listed on Nasdaq Helsinki.